17 Dec 2020 07:00
Intelligent Ultrasound Group plc
("the Company")
Change of ticker
Intelligent Ultrasound Group plc (AIM: IUG), the ultrasound artificial intelligence (AI) software and simulation company, announces that the Company's London Stock Exchange ticker will change from MED to IUG from Monday 21 December.
This change should help investors to more easily identify the shares on the London Stock Exchange and investment platforms, when they use the initials of the Company (Intelligent Ultrasound Group).
All other Company details will remain the same, including the Company's name, ISIN, SEDOL and LEI.
For further information, please contact:
Intelligent Ultrasound Group plc | www. intelligentultrasound.com | ||||
Stuart Gall, CEO Helen Jones, CFO | Tel: +44 (0)29 2075 6534 | ||||
Cenkos Securities - Nominated Advisor and Broker | Tel: +44 (0)20 7397 8900 | ||||
Giles Balleny / Cameron MacRitchie (Corporate Finance) | |||||
Michael Johnson / Julian Morse (Sales) | |||||
Walbrook PR | Tel: +44 (0)20 7933 8780 or intelligentultrasound@walbrookpr.com | ||||
Anna Dunphy / Paul McManus | Mob: +44 (0)7876 741 001 / Mob: +44 (0)7980 541 893 | ||||
About Intelligent Ultrasound Group
Intelligent Ultrasound (AIM: IUG) develops artificial intelligence-based clinical image analysis software tools for the diagnostic medical ultrasound market and hi-fidelity virtual reality simulators for the ultrasound training market. Based in Cardiff in the UK and Atlanta in the US, the Group operates two divisions:
Clinical AI Division
Focusses on developing deep learning-based algorithms to make ultrasound machines smarter and more accessible. Products in the market include ScanNav Assist, which uses machine-learning based algorithms to automatically identify and grade ultrasound images. GE Healthcare's SonoLyst software on their Voluson SWIFT ultrasound machine incorporates the ScanNav Assist AI technology and has received 510(k) clearance from the FDA for sale in the USA. SonoLyst is the world's first fully integrated AI tool that recognises the 20 views recommended by the International Society of Ultrasound in Obstetrics and Gynaecology mid-trimester practice guidelines for fetal imaging.
Products in development include ScanNav Anatomy PNB, which aims to simplify ultrasound-guided needling by providing the user with real-time AI-based anatomy highlighting software for a range of medical procedures. ScanNav Anatomy has been submitted for CE and FDA regulatory approval.
Simulation Division
Focusses on hi-fidelity ultrasound education and training through simulation. Its three main products are the ScanTrainer OBGYN training simulator, the HeartWorks echocardiography training simulator and the BodyWorks Eve Point of Care and Emergency Medicine training simulator. To date almost 1,000 simulators have been sold to over 600 medical institutions around the world.
www.intelligentultrasound.com